Key Takeaways

  • LGEN repurchased 12,578,843 ordinary shares of 2.5p each over a five-day window from 18 to 22 May 2026.
  • Barclays Capital Securities Limited acted as broker, executing trades on XLON, BATE, TRQX, AQXE and CHIX venues.
  • All shares will be cancelled, not held in treasury, leaving 5,560,642,468 ordinary shares in issue.
  • The buyback is a continuation of LGEN’s 2026 capital return programme announced on 11 March 2026.
  • The London Stock Exchange announcement was released through RNS at 18:15 on 26 May 2026 under RNS Number 7357F.

Introduction

Legal & General Group Plc (LSE:LGEN), one of the United Kingdom’s largest insurance and asset management businesses and a long-standing constituent of the FTSE 100, has provided a fresh update on its ongoing share buyback programme. In a Regulatory News Service (RNS) announcement released through the London Stock Exchange on 26 May 2026 at 18:15, the company confirmed that it had purchased a total of 12,578,843 of its own ordinary shares over the five trading days from 18 May 2026 to 22 May 2026. The repurchases are part of the wider capital return strategy that the group set out on 11 March 2026, and all of the shares acquired during the period will be cancelled rather than held in treasury. For investors tracking FTSE shares, the regular cadence of these transaction in own shares notices has become a closely watched indicator of how Legal & General is deploying its surplus capital.

What the Company Announced

In the London Stock Exchange announcement, Legal & General Group Plc — trading under the ticker LGEN and identified by its LEI number 213800JH9QQWHLO99821 and ISIN GB0005603997 — reported that, between 18 May 2026 and 22 May 2026 inclusive, it had purchased a total of 12,578,843 ordinary shares of 2.5 pence each through Barclays Capital Securities Limited. The announcement makes clear that the repurchased ordinary shares will be cancelled. Following settlement and cancellation, the company’s total number of ordinary shares in issue will fall to 5,560,642,468, with no shares held in treasury. The number of voting rights — also 5,560,642,468 — is the figure that shareholders may use as the denominator for calculations under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The announcement indicates that the purchases form part of the buyback programme announced on 11 March 2026 and that a detailed schedule of individual trades by Barclays is published as a separate PDF on the LSE’s RNS PDF service.

Details of the Own-Share Transaction

The disclosure aggregates trading across five venues — XLON (London Stock Exchange), BATE (Cboe BXE), TRQX (Turquoise), AQXE (Aquis Exchange) and CHIX (Cboe CXE) — across each of the five trading days. According to the published table, prices paid for individual lots ranged from a low of 260.70p on 18 May 2026 to a high of 270.00p on 22 May 2026. Volume-weighted average prices (VWAPs) climbed steadily over the week, broadly tracking the rising intra-week share price.

Aggregated Daily Volumes and Price Range

  • 18 May 2026: approximately 1,999,000 shares purchased across XLON, BATE, TRQX, AQXE and CHIX at VWAPs between 263.43p and 264.16p, in a range of 260.70p to 265.90p.
  • 19 May 2026: approximately 1,000,000 shares purchased at VWAPs between 265.46p and 265.64p, in a range of 262.90p to 267.00p.
  • 20 May 2026: the largest day, with around 5,981,566 shares purchased at VWAPs between 264.89p and 265.75p, in a range of 262.60p to 269.10p.
  • 21 May 2026: approximately 2,000,000 shares purchased at VWAPs between 267.83p and 268.06p, in a range of 266.40p to 269.00p.
  • 22 May 2026: approximately 1,597,277 shares purchased at VWAPs between 269.10p and 269.50p, in a range of 267.50p to 270.00p.

Taken together, the prices paid suggest a blended cost in the region of the mid-to-high 260p range, implying an aggregate consideration broadly approaching £33 million for the week. The exact aggregate cash outflow is not disclosed in the announcement itself, although Market Participants can calculate an indicative figure from the published volumes and volume-weighted average prices. The detailed trade-by-trade schedule is available on the LSE RNS PDF service for those investors who want to inspect every individual print.

Why Companies Buy Back Their Own Shares

A share buyback is one of the main ways a listed company can return surplus capital to shareholders, alongside dividends. When a company conducts a transaction in own shares and subsequently cancels those shares, the total number of ordinary shares in issue falls. All else equal, this typically increases Earnings Per Share, since the same profit pool is shared among fewer shares. Buybacks can also be deployed as a flexible tool to manage Capital Structure, to offset dilution from employee share schemes, or simply to signal management’s confidence that the shares represent good value at prevailing prices. Market participants often view buybacks as a vote of confidence from the board, although the precise interpretation will depend on the company’s wider capital position, Dividend policy and outlook. For UK insurers like Legal & General, buybacks have become a familiar feature of the capital return toolkit, sitting alongside the ordinary dividend.

What This May Signal to Investors

Because Legal & General’s latest LSE announcement explicitly references a wider buyback programme launched on 11 March 2026, the 18–22 May purchases should be read as a continuation rather than a new initiative. The fact that the company is executing buybacks consistently — and across multiple venues with a recognised broker like Barclays Capital Securities Limited — suggests an orderly, systematic approach to returning capital. Investors may watch the cumulative size of the programme, the average price paid versus the prevailing Market Price, and any commentary on capital generation at upcoming results. The announcement indicates that LGEN is comfortable continuing to deploy capital on its own shares, but it should not be read as a forecast of any particular share price direction. Buybacks reduce share count and may support earnings per share metrics, yet the ultimate market reaction depends on broader factors including interest rates, the outlook for UK insurance margins, and Shareholder expectations around dividends.

Company Background

Legal & General Group Plc is one of the United Kingdom’s most established financial services groups, with roots going back to 1836. Today it is a leading provider of risk transfer solutions for pension schemes, individual retirement income products, Investment management through Legal & General Investment Management (LGIM), and Capital Investment in Assets such as housing, infrastructure and clean energy. The group is a FTSE 100 constituent and one of the largest UK-listed insurers by Market Capitalisation. Legal & General has historically combined a substantial ordinary dividend with periodic capital returns, and its 2026 buyback programme is part of that broader pattern. The company’s ISIN is GB0005603997 and its LEI is 213800JH9QQWHLO99821 — identifiers that allow investors and data providers to track its securities and regulatory filings with precision.

Market and Sector Context

Share buybacks have become an increasingly prominent feature of the FTSE 100 landscape, with UK banks, oil majors and insurers all returning meaningful amounts of capital to shareholders in recent years. UK insurance stocks in particular have leaned on a combination of dividends and buybacks to demonstrate the cash-generative nature of their businesses, especially in the bulk Annuity and pension risk transfer market where Legal & General has been one of the most active participants. Against that backdrop, LGEN’s steady execution of its 2026 programme is consistent with the wider sector trend of returning surplus capital while continuing to invest in long-duration liabilities. Market participants often compare buyback yields across the FTSE to assess relative capital return attractiveness, and Legal & General’s programme contributes to its overall total shareholder return profile alongside the dividend.

Potential Impact on Shareholders

From a shareholder perspective, the most direct effect of the latest transaction is the reduction in the total number of ordinary shares in issue to 5,560,642,468 once the 12,578,843 newly purchased shares have been cancelled. With no ordinary shares held in treasury, every existing investor’s proportionate ownership of Legal & General rises very slightly. Over time, sustained buyback activity can support earnings per share, Dividend per share growth and, potentially, Return on Equity metrics, although the actual outcome depends on profitability, capital generation and the prices at which shares are repurchased. The total number of voting rights in the Company also stands at 5,560,642,468, which is the figure shareholders may use as the denominator for calculations under the FCA’s Disclosure Guidance and Transparency Rules to determine whether they are required to notify their interest, or any change in that interest, in Legal & General.

Risks and Points Investors Should Watch

No buyback programme is without risk. Investors may watch whether Legal & General’s capital generation continues to support the pace of repurchases without compromising regulatory capital ratios or its capacity to write profitable new Business. The announcement indicates that LGEN remains committed to its 11 March 2026 buyback, but external conditions — including Interest Rate Volatility, Credit spread movements, Inflation trends and developments in the bulk annuity market — could influence both the amount and timing of future purchases. Other points to monitor include the average price at which shares are being repurchased versus market consensus on Intrinsic Value, the size of any remaining authorised buyback capacity, and how management communicates progress at interim and full-year results. Macroeconomic shocks, regulatory change in the UK insurance sector, and shifts in shareholder expectations around dividend cover could all alter the relative attractiveness of buybacks versus alternative uses of capital.

What Happens Next

Following this London Stock Exchange announcement, attention will turn to whether Legal & General continues to issue further transaction in own shares notices in the coming days and weeks. Each subsequent RNS update will provide a fresh data point on the pace, price and venue mix of the buyback. Investors should also watch for any commentary at the company’s next scheduled corporate update, where management may quantify the remaining headroom under the 11 March 2026 buyback authority. As the cancellation of the 12,578,843 ordinary shares settles, regulated databases and index providers will update their records to reflect the new share count of 5,560,642,468 ordinary shares in issue.

Conclusion

The 26 May 2026 RNS announcement is an incremental but important data point in Legal & General’s 2026 capital return story. By purchasing 12,578,843 ordinary shares over the week of 18–22 May 2026 through Barclays Capital Securities Limited and committing to cancel them, LGEN has continued to execute the buyback programme it announced on 11 March 2026 in a steady, multi-venue fashion. For investors in UK stocks, particularly those following FTSE 100 insurance names, the disclosure adds further colour to the company’s capital return profile and reinforces the role buybacks now play in the LGEN shareholder return mix. As always, market participants will weigh the announcement against the broader macro and sector backdrop rather than reading it in isolation.